Buscar resultados de ensayos clínicos
Pituitary ACTH Hypersecretion - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Treatment of Cushing's Disease With R-roscovitine Condición: Cushings Disease Fecha: 2014-05-21 Intervenciones: Drug: R-roscovitine See Arm Description Other Names: |
Recruiting |
Nombre del estudio: Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease Condición: Cushing's Disease Fecha: 2014-06-17 Intervenciones: Drug: LCI699 |
Active, not recruiting |
Nombre del estudio: Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease Condición: Cushing's Disease Fecha: 2013-06-10 Intervenciones: Drug: Pasireotide with or without cabergoline The trial consists of Pasireotide-untreated patients will |
Recruiting |
Nombre del estudio: Cushing's Disease Complications Condición: Cushing's Disease Fecha: 2015-07-20 Intervenciones: Other: Exams and questionnaires Blood sample 24hrs urinary cortisol and salivary cortisol, urinary labst |
Completed |
Nombre del estudio: Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease Condición: Cushing Disease Fecha: 2005-09-13 Intervenciones: Drug: Pasireotide |
Completed |
Nombre del estudio: Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease Condición: Cushing's Disease Fecha: 2011-06-14 Intervenciones:
|
Recruiting |
Nombre del estudio: Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease Condición: Cushings Disease Fecha: 2014-09-26 Intervenciones: Drug: SOM230 |
Completed |
Nombre del estudio: Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease Condición: Cushing's Disease Fecha: 2007-02-09 Intervenciones: Drug: Pasireotide |
Active, not recruiting |
Nombre del estudio: Safety and Efficacy of LCI699 in Cushing's Disease Patients. Condición: Cushing's Disease Fecha: 2011-04-06 Intervenciones: Drug: LCI699 |
Completed |
Nombre del estudio: An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Condición: Cushing's Disease Fecha: 2012-04-12 Intervenciones: Drug: Pasireotide sub-cutaneous formulation Pasireotide will be administered twice a day until pasireoti |